{"contentid": 487904, "importid": NaN, "name": "EFPIA weighs in on supply chain security", "introduction": "The European Federation of Pharmaceutical Industries and Associations (EFPIA) has welcomed the opportunity to participate in the European Commission\u00e2\u0080\u0099s structured dialogue on supply chain security.", "content": "<p>The European Federation of Pharmaceutical Industries and Associations (EFPIA) has welcomed the opportunity to participate in the European Commission&rsquo;s structured dialogue on supply chain security.</p>\n<p>The EFPIA claims that it is critical that any proposals from the structured dialogue take into account the nuances between the different actors across the medicines and vaccines supply chains.</p>\n<p><span class=\"pullQuote\">\"Europe needs longer-term investment, incentives and global regulatory harmonization in order to build a strong innovative manufacturing and supply ecosystem\"</span>EUROSTAT data shows that the European Union (EU) is a strong exporter of pharmaceutical products, and in terms of imports, is resilient because most come from the EU itself, the group stressed.</p>\n<p>For example, the research-based, innovative pharmaceutical industry sources 77% of its active pharmaceutical ingredients from within Europe. Some 12% are from the USA, with only 9% being sourced from Asia.</p>\n<p>The EFPIA pointed out that the EU is the largest exporter of medicines in the world, with a global market share of 63.8%, and Vaccines Europe members manufacture 76% of their vaccines within the EU.</p>\n<p>Philippe Luscan, executive vice president, global industrial affairs, Sanofi (Euronext: SAN), said: &ldquo;COVID-19 has shown the strength and resilience of global supply chains, demonstrating our capacity to quickly ramp up and increase manufacturing to limit any shortages of essential medicines. To remain competitive, Europe needs longer-term investment, incentives and global regulatory harmonization in order to build a strong innovative manufacturing and supply ecosystem for the therapies of the future, such as mRNA, cell &amp; gene therapy delivery and other types of highly specialised and innovative technologies.&rdquo;</p>\n<p>EFPIA director general, Nathalie Moll, added: &ldquo;We welcome the commission&rsquo;s recognition that collaboration and partnership is key to supply chain security and that health is of strategic importance to the EU.</p>\n<p>&ldquo;Our recent experience in discovering, developing and delivering COVID-19 vaccines and therapeutics has underlined that resilience begins with our research and development eco-system as well as the paramount importance of resilient global supply chains.&rdquo;</p>\n<p>&nbsp;</p>", "date": "2021-03-01 14:46:00", "meta_title": NaN, "meta_keywords": "supply, EFPIA, European, chain, security, pharmaceutical, global, Europe, dialogue, structured, innovative, vaccines, strong, manufacturing, weighs, build", "meta_description": "The European Federation of Pharmaceutical Industries and Associations (EFPIA) has welcomed the opportunity to participate in the European Commission\u00e2\u0080\u0099s structure", "meta_robots": NaN, "meta_display_in_sitemap": 1, "canonical_url": NaN, "status": 3, "access_status": 0, "ignore_flexible_sampling": 0, "display_start_date": "0000-00-00 00:00:00", "display_end_date": "0000-00-00 00:00:00", "display_in_search": 1, "created": "2021-03-01 14:38:45", "updated": "2021-03-01 15:33:26", "access": NaN, "url": "https://www.thepharmaletter.com/article/efpia-weighs-in-on-supply-chain-security", "description": NaN, "twitter_term": NaN, "twitter_widgetid": NaN, "key_facts": NaN, "news_snippet": NaN, "image1id": "efpia-big-3.png", "image2id": "efpia-small-1.png", "restrict_print": 0, "restrict_print_for_logged_out": 0, "box1_header": NaN, "box1_title": NaN, "box1_image1id": 0, "box1_url": NaN, "box1_introduction": NaN, "box1_position": 0, "tags": NaN, "sector_tag": "Pharmaceutical", "therapy area_tag": NaN, "topic_tag": "Coronavirus, Focus On, Government Affairs, Health Medical Pharma", "geography_tag": "Europe", "company_tag": "EFPIA, Sanofi", "drug_tag": NaN, "market index_tag": NaN, "theme_tag": NaN, "industry sector_tag": NaN, "medical condition_tag": NaN, "industry term_tag": NaN, "organization_tag": NaN, "person_tag": NaN, "position_tag": NaN, "medical treatment_tag": NaN, "facility_tag": NaN, "technology_tag": NaN, "journalist_tag": NaN, "published medium_tag": NaN, "political event_tag": NaN, "anniversary_tag": NaN, "sports event_tag": NaN, "movie_tag": NaN, "fax number_tag": NaN, "currency pair_tag": NaN, "sports league_tag": NaN, "date_tag": NaN, "music group_tag": NaN, "phone number_tag": NaN, "t v show_tag": NaN, "t v station_tag": NaN, "entertainment award event_tag": NaN, "industry_tag": NaN, "pharmaceutical drug_tag": NaN, "topmost public parent company_tag": NaN, "content_type_name": "Article", "pubDate": "2021-03-01 14:46:00"}